Project Grant R01EY036923
Award Date
1/1/25
Completion Date
12/31/29
Dollars Obligated
$387K
Federal Agency
National Eye Institute
Federal Grant Program
93.867
Assistance Type
Project Grant
Place of Performance
Newark, DE, USA
Similar Awards
This Project Grant award from the National Eye Institute (CFDA 93.867 - Vision Research) provides $214,227 to Miami University to utilize the chicken embryo model to study the transcriptional regulation of the FOXE3 gene, which is critical for lens development. The research aims to identify and functionally test the cis-regulatory elements and transcription factors that control FOXE3 expression in the lens, with the goal of enhancing the understanding of how transcription factors regulate gene...
The National Eye Institute (NEI), under the U.S. Department of Health and Human Services, awarded a $143,569 Project Grant (CFDA 93.867 - Vision Research) to the Rochester Institute of Technology (RIT) to conduct research on the phase boundaries and liquid structure of concentrated eye lens protein mixtures. The key objectives of this 4-year research project (7/1/2025 - 6/30/2029) are to: (1) test predictions of molecular models of gamma crystallin interactions, (2) study how beta crystallin...
This federal Project Grant award, provided by the National Eye Institute (CFDA 93.867 Vision Research), supports research at the Whitehead Institute for Biomedical Research to systematically identify and characterize novel oxidative protective genes that can prevent retinal pigment epithelium (RPE) degeneration and age-related macular degeneration (AMD). The $173,016 award, effective from Aug 1, 2025 to Jul 31, 2027, will fund a project focused on three primary aims: 1) elucidating the...
This Project Grant award from the National Eye Institute (NEI), under the Vision Research federal grant program (CFDA 93.867), supports research to understand the development and function of corneal lens-secreting cells in the human eye. The $543,037 award, effective September 1, 2024 through May 31, 2028, will fund investigations into the genetic and molecular mechanisms underlying corneal development and function. Key research objectives include identifying transcription factors and...
This Project Grant award from the National Eye Institute (CFDA 93.867 - Vision Research) provides $1,241,223 to the University of Pittsburgh to conduct research on the genetic and epigenetic circuits underlying retinal transcription programs and how perturbations in the retinal core regulatory networks lead to congenital vision disorders. The key objectives are to: 1) Use mouse models to dissect the molecular, cellular, and genomic effects of genetic mutations on retinal development; 2)...
This $148,568 Project Grant award from the National Eye Institute (NEI), under the federal Vision Research program (CFDA 93.867), supports research at Emory University to investigate the role of scleral fibroblasts in refractive development and myopia. The primary objectives are to: 1) Identify characteristics of scleral fibroblasts in mouse eyes that undergo normal refractive development versus those exposed to myopic stimuli, and 2) Determine the role of retinoic acid signaling in driving...
This Project Grant award, funded by the National Eye Institute (NEI) under the Vision Research federal grant program (CFDA 93.867), supports a research project focused on understanding genetic and glial support mechanisms in acute and chronic models of photoreceptor degeneration. The total award amount is $385,000.00 over a 4-year period from August 1, 2025 to July 31, 2029. The project, led by researchers at Wayne State University, aims to compare the transcriptional, cellular, and functional...
This Project Grant award from the National Eye Institute (CFDA 93.867 - Vision Research) provides $146,922 to support research to understand the chromatin architectural landscape of retinal development at the single-cell level. The key objectives are to: 1) Capture 3D chromatin interactions of mouse retinal cells at key developmental stages using single-cell Hi-C (Aim 1); and 2) Identify changes in chromatin organization associated with retinal progenitor-specific loss-of-function of the NFI...
This Project Grant award from the National Eye Institute (NEI), under the Vision Research federal grant program (CFDA 93.867), supports the development of a novel genetic screening approach termed "Mosaic In Vivo Perturbation (MVP)" to systematically assess gene function in the eye. The $1,387,142 award, effective September 1, 2024 through June 30, 2028, will enable researchers at President and Fellows of Harvard College (Harvard Medical School) to optimize the MVP approach, develop an...
This Project Grant award from the National Eye Institute (NEI), under the federal Vision Research program (CFDA 93.867), will fund research to understand the genetic causes of inherited retinal degenerations (IRDs), a group of rare blinding diseases. The $1,369,782 award to the Massachusetts Eye and Ear Infirmary will support two key research aims: Developing a high-throughput splicing assay to identify rare coding and non-coding variants that lead to splicing defects and contribute to the...